Skip to content
2000
Volume 4, Issue 3
  • ISSN: 1872-2113
  • E-ISSN: 2212-4039

Abstract

Orally disintegrating tablets (ODTs) offer many advantages over the conventional oral dosage forms in terms of convenience and ease of use. Over the last decade, substantial advances in the formulation of ODTs have been achieved in academia and industry that resulted in the emerging of a large number of patents. The aim of this review is to summarise the most recent patents in ODT formulations and highlight their motivations, inventive steps and significances in the development of ODT formulations. Five major techniques have been applied in manufacturing of ODTs, namely conventional tablet press, moulding, freeze drying, tablet loading and pulverization, with majority of the patents dedicated to the use of conventional tablet pressing. The patents have addressed various issues concerning the manufacturing of robust and practical ODT formulations by disclosing new manufacturing techniques, advantageous materials, and innovative formulation steps. However, future developments are required to reduce the cost and widening the application of the new manufacturing techniques, while simplifying and shortening the formulation steps will be crucial in the well established ones.

Loading

Article metrics loading...

/content/journals/ddf/10.2174/187221110793237574
2010-11-01
2025-10-06
Loading full text...

Full text loading...

/content/journals/ddf/10.2174/187221110793237574
Loading

  • Article Type:
    Research Article
Keyword(s): acacia; acetaminophen; Acetaminophen; agar; agglomerates; agglomeration; amoxicillin; anhydrous silicic acid; Antibiotics; antiemetic activity; aspartame; aspirin; azeotropic mixtures; bioavailability; compression; Conventional Tablet Press; Corn starch; corn starch synergises; cosmetic; croscarmellose cellulose); crospovidone; cushioning components; D-mannitol; diluents; disintegration mechanism; Domperidone; dysphagia; effervescent acid (malic acid); erythritol; ethanol; excipient; flavouring agents; Flow agent; fluoroalkanes; fracturability; freeze drying; Galanthamine hydrobromide; gastrokinetic; geriatric patients; glidants; Glidants; granulation-compression; guar; humectant; hydroxypropyl- cellulose; Ibuprofen; ketoprofen; lansoprazole; Lansoprazole; Lower critical solution temperature; lubricant; lubricants; magnesium hydroxide; Manufacturing; matrix forming agents; Meloxicam; Melt-granulation; methacrylic acid copolymers; microcrystalline cellulose; Micronised; Mitiglinide Calcium hydrate; mouldability; moulding; N-acetylglucosamine; Neutral core; nifidipine; no-vacuum lyophilisation; nutraceutical; Ondansetron; Orally disintegrating tablets; oxycodone; Oxycodone; Parkinson's disease; pellets; permeabilizing agents; polymethacrylate; polyvinyl alcohol; polyvinylpyrrolidone; prophylaxis; pulverization; Ranitidine salt; Saccharrides; salivating agents; sclerosis; Sieving; silicified microcrystalline; silicified microcrystalline cellulose; Spray drying; starch; Starch clays (kaolin); steroidal anti-inflammatory drugs; stevia; Surfactant; temazepam; thermo-labile; Titanium dioxide; Valdecoxib; water-soluble excipients; wicking effect; xanthan gum
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test